Cargando…

Doxycycline-Induced Autoimmune Hepatitis

Doxycycline and minocycline are tetracyclines with the potential to cause hepatoxicity. Although autoimmune-like hepatitis from minocycline is well-described, doxycycline-induced autoimmune hepatitis (DIAH) has only been described once. We report a rare case of DIAH with elevated liver enzymes over...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Jason Jeng, Promrat, Kittichai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423905/
https://www.ncbi.nlm.nih.gov/pubmed/32821768
http://dx.doi.org/10.14309/crj.0000000000000440
_version_ 1783570222165262336
author Pan, Jason Jeng
Promrat, Kittichai
author_facet Pan, Jason Jeng
Promrat, Kittichai
author_sort Pan, Jason Jeng
collection PubMed
description Doxycycline and minocycline are tetracyclines with the potential to cause hepatoxicity. Although autoimmune-like hepatitis from minocycline is well-described, doxycycline-induced autoimmune hepatitis (DIAH) has only been described once. We report a rare case of DIAH with elevated liver enzymes over 5 times the normal upper limit, elevated immunoglobulin G, and high titers of antismooth muscle antibody and antinuclear antibody. By stopping doxycycline, our patient's liver enzymes normalized and immunoglobulin G and autoantibody titers rapidly downtrended. As long-term doxycycline therapy becomes more prevalent to treat acne vulgaris and other skin conditions, DIAH may become more prevalent and recognized.
format Online
Article
Text
id pubmed-7423905
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-74239052020-08-19 Doxycycline-Induced Autoimmune Hepatitis Pan, Jason Jeng Promrat, Kittichai ACG Case Rep J Case Report Doxycycline and minocycline are tetracyclines with the potential to cause hepatoxicity. Although autoimmune-like hepatitis from minocycline is well-described, doxycycline-induced autoimmune hepatitis (DIAH) has only been described once. We report a rare case of DIAH with elevated liver enzymes over 5 times the normal upper limit, elevated immunoglobulin G, and high titers of antismooth muscle antibody and antinuclear antibody. By stopping doxycycline, our patient's liver enzymes normalized and immunoglobulin G and autoantibody titers rapidly downtrended. As long-term doxycycline therapy becomes more prevalent to treat acne vulgaris and other skin conditions, DIAH may become more prevalent and recognized. Wolters Kluwer 2020-08-10 /pmc/articles/PMC7423905/ /pubmed/32821768 http://dx.doi.org/10.14309/crj.0000000000000440 Text en © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Case Report
Pan, Jason Jeng
Promrat, Kittichai
Doxycycline-Induced Autoimmune Hepatitis
title Doxycycline-Induced Autoimmune Hepatitis
title_full Doxycycline-Induced Autoimmune Hepatitis
title_fullStr Doxycycline-Induced Autoimmune Hepatitis
title_full_unstemmed Doxycycline-Induced Autoimmune Hepatitis
title_short Doxycycline-Induced Autoimmune Hepatitis
title_sort doxycycline-induced autoimmune hepatitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423905/
https://www.ncbi.nlm.nih.gov/pubmed/32821768
http://dx.doi.org/10.14309/crj.0000000000000440
work_keys_str_mv AT panjasonjeng doxycyclineinducedautoimmunehepatitis
AT promratkittichai doxycyclineinducedautoimmunehepatitis